Fluorescein dilaurate test of pancreatic function

Continued Atlantic overturning circulation even under climate extremes.

Nature·2025

Ediacaran metazoan reveals lophotrochozoan affinity and deepens root of Cambrian Explosion.

Science advances·2021

Regional nutrient decrease drove redox stabilisation and metazoan diversification in the late Ediacaran Nama Group, Namibia.

Scientific reports·2020

Early-life gut microbiome and egg allergy.

Allergy·2018

The use of omalizumab in allergen immunotherapy.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2018

Controls on the evolution of Ediacaran metazoan ecosystems: A redox perspective.

Geobiology·2017

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

The Turkish validity and reliability of the Distress Tolerance Scale in youth in a clinical sample.

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Validity and reliability of the Frith-Happé Animation Test in a Turkish sample.

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Validity and reliability study of the Turkish version of the Addiction Severity Index.

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Bayesian Graded Response Models for Eating-Disorder Risk Estimation Using Screening Data.

Computational brain & behavior·2026

The Dynamic Affect Recognition Test: Construction and Validation in Neurodegenerative Syndromes.

Assessment·2026

Public thresholds for antidepressant effectiveness and adverse drug reaction rates: a cross-sectional study.

Scientific reports·2026

Related Experiment Videos

Fluorescein dilaurate test of pancreatic function

Related Concept Videos

Continued Atlantic overturning circulation even under climate extremes.

Ediacaran metazoan reveals lophotrochozoan affinity and deepens root of Cambrian Explosion.

Regional nutrient decrease drove redox stabilisation and metazoan diversification in the late Ediacaran Nama Group, Namibia.

Early-life gut microbiome and egg allergy.

The use of omalizumab in allergen immunotherapy.

Controls on the evolution of Ediacaran metazoan ecosystems: A redox perspective.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

The Turkish validity and reliability of the Distress Tolerance Scale in youth in a clinical sample.

Validity and reliability of the Frith-Happé Animation Test in a Turkish sample.

Validity and reliability study of the Turkish version of the Addiction Severity Index.

Bayesian Graded Response Models for Eating-Disorder Risk Estimation Using Screening Data.

The Dynamic Affect Recognition Test: Construction and Validation in Neurodegenerative Syndromes.

Public thresholds for antidepressant effectiveness and adverse drug reaction rates: a cross-sectional study.

Related Experiment Videos

Fluorescein dilaurate test of pancreatic function

Related Concept Videos

Related Articles